SC 13G
SOLENO THERAPEUTICS, INC.
- Company
- SOLENO THERAPEUTICS INC
- Filed
- November 14, 2024
- Accession Number
- 0000902664-24-006528
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →